INM-176

N/A

Report date: 2024/10/30 20:00:43
NME

Base Information

Drug NameINM-176
Drug Alias NameAlzhima 176KR-WAP-026Win-025INM-176K-1107 +[6
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionProteins inhibitors
TargetsProteins
Therapy Area/IndicationsAlzheimer DiseaseProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesScigenics
China Registration ClassN/A

Develop Information

Active IndicationsProstatic Neoplasms
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A